Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| A5951060 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will treat patients who have a short term central catheter that is thought to be infected with a specific bacteria (gram positive bacteria)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Linezolid | Drug |
| ||
| Vancomycin | Drug | |||
| Oxacillin | Drug | |||
| Dicloxacillin | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| The empiric treatment of patients with complicated skin and skin structure infections (cSSSI) related to an indwelling catheter; | ||
| The empiric treatment of patients with gram-positive catheter-related bloodstream infections. |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical efficacy of linezolid compared to vancomycin/oxacillin/dicloxacillin.2.Incidence of late metastatic sequelae associated with S. aureus infections in patients treated with linezolid |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
Not provided
Not provided
| Label | URL |
|---|---|
| Link to FDA Alert | View source |
Not provided
| ID | Term |
|---|---|
| D001424 | Bacterial Infections |
| D016908 | Gram-Positive Bacterial Infections |
| D016470 | Bacteremia |
| ID | Term |
|---|---|
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D018805 | Sepsis |
| D018746 | Systemic Inflammatory Response Syndrome |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069349 | Linezolid |
| D014640 | Vancomycin |
| D010068 | Oxacillin |
| D004009 | Dicloxacillin |
| ID | Term |
|---|---|
| D000081 | Acetamides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000085 | Acetates |
| D000144 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D023303 | Oxazolidinones |
| D010080 | Oxazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D006020 | Glycopeptides |
| D006001 | Glycoconjugates |
| D002241 | Carbohydrates |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D010406 | Penicillins |
| D047090 | beta-Lactams |
| D007769 | Lactams |
| D013457 | Sulfur Compounds |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D003023 | Cloxacillin |